Espo Home 10 mg (Dapagliflozin)
Dapagliflozin 10mg
Tablet · Prescription medication
Samchundang Pharm. Co., Ltd.
MFDS item code 202004453 · Approved 2020.06.17
This product's status changed to Expired on 2025.06.17. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement of glycemic control in type 2 diabetes mellitus
This medication is prescribed to assist in blood glucose control for patients with type 2 diabetes. It can be used alone or in combination with Metformin, Sulfonylureas, Insulin, Sitagliptin, etc., in cases where previous diabetes treatments have not effectively controlled blood glucose levels. Its ability to be combined with various medications allows for flexible blood glucose management tailored to the patient's condition. In summary, this medication effectively manages blood glucose through either monotherapy or various combination therapies to improve diabetes treatment.
Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this medication is 10mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, such as insulin. When this medication is used in combination with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients who have not previously received pharmacological treatment for diabetes, when this medication is administered in combination with metformin, the recommended initial dose is 5mg once daily or 10mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Use of this medication is not recommended for the purpose of improving glycemic control. - Patients on dialysis: Do not administer this medication. Hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, an initial dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Elderly patients (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This medication may be administered orally once daily at any time of day, with or without food. The tablet should be swallowed whole.
The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.
This medication should not be used in certain patients. It is contraindicated in those with allergies to the active ingredient or excipients, as well as in patients with type 1 diabetes, diabetic ketoacidosis, and those undergoing dialysis. Use with caution in patients with low fluid volume or impaired kidney function. This medication can cause low blood pressure or temporary worsening of kidney function; therefore, fluid status and kidney function should be checked prior to treatment and continuously monitored thereafter. Blood glucose control may vary with kidney function; therefore, it is not recommended for patients with moderate to severe renal impairment. This medication can increase the risk of infections such as genital infections and urinary tract infections, especially in women or those with a history of infections. Additionally, the risk of hypoglycemia may increase when used in conjunction with medications such as insulin or sulfonylureas, requiring dosage adjustments for these medications. Dehydration or hypotension symptoms may occur due to decreased fluid volume, so if symptoms arise, consult a doctor immediately. Rarely, this medication can cause severe infections such as Fournier's gangrene. Therefore, seek immediate treatment if you experience pain, swelling, or redness around the genital area. It is advisable for pregnant or breastfeeding women to avoid this medication, and treatment should be discontinued if pregnancy is confirmed. Elderly individuals or those with impaired kidney function have an increased risk of side effects from this medication and require careful observation and management. This medication does not significantly affect the ability to drive or operate machinery, but caution is needed when used in combination with medications that have a risk of hypoglycemia. Finally, the safety and efficacy of this medication have not been established in pediatric patients, so it is preferable not to use it in children.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. It is recommended to maintain a storage temperature between 1 and 30 degrees Celsius to safely preserve the medication's efficacy.
Yellow, film-coated, double convex rhomboid tablet
Bottle - 100 tablets/bottle, PTP - 8 tablets/box [8 tablets/Alu-Alu x 1]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Dapagliflozin 10mg
Tablet · Prescription medication
Samchundang Pharm. Co., Ltd.

Dapagliflozin 10mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Dapagliflozin 5mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Dapagliflozin 10mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Dapagliflozin 10mg
Tablet · Prescription medication
Korea Prime Pharma Co., Ltd.
Dapagliflozin 10mg
Tablet · Prescription medication
Withus Pharmaceutical Co., Ltd.
Dapagliflozin 10mg
Tablet · Prescription medication
IYUN Pharmaceutical Co., Ltd.
Dapagliflozin 10mg
Tablet · Prescription medication
Litepharmtech Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.